Hennion & Walsh Asset Management’s Epizyme, Inc EPZM Stock Holding History

Hennion & Walsh Asset Management’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-332,004	Closed	-$488K	–	810
2022 Q2	$488K	Sell	332,004 -10,823	-3%	-$7.95K	0.03%	485
2022 Q1	$394K	Sell	342,827 -4,003	-1%	-$6.53K	0.02%	566
2021 Q4	$867K	Sell	346,830 -97,168	-22%	-$382K	0.04%	404
2021 Q3	$2.27M	Buy	443,998 +37,821	+9%	+$230K	0.12%	225
2021 Q2	$3.38M	Buy	406,177 +120,615	+42%	+$1.02M	0.18%	155
2021 Q1	$2.49M	Buy	+285,562	New	+$2.95M	0.15%	193

Other funds holding EPZM

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Hennion & Walsh Asset Management's EPZM Position: Q3 2022 in Review

Hennion & Walsh Asset Management sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 332,004 shares — an estimated $488K sold.

Hennion & Walsh Asset Management first reported a position in EPZM in Q1 2021 and held it in 6 quarters. The position peaked at $3.38M in Q2 2021. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

Hennion & Walsh Asset Management reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
Hennion & Walsh Asset Management sold 332,004 Epizyme, Inc shares in Q3 2022, an estimated $488K.
Hennion & Walsh Asset Management first reported a position in Epizyme, Inc in Q1 2021 and held it in 6 quarters.
Hennion & Walsh Asset Management's Epizyme, Inc position peaked at $3.38M in Q2 2021.
0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on Hennion & Walsh Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.